Long-term prognostic value of dobutamine stress echocardiography in diabetic patients with limited exercise capability: A 13-year follow-up study

Diabetes Care

Volumn 35, Issue 3, 2012, Pages 634-639

  Van Der Sijde, Jors N ^a   Boiten, Henk J ^a   Sozzi, Fabiola B ^b   Elhendy, Abdou ^c   Van Domburg, Ron T ^a   Schinkel, Arend F L ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Istitudo di Ricovero e Cura a Carattere Scientifico Multimedia Scientific and Technology Pole   (Italy)

^c MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; DOBUTAMINE; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ADVERSE OUTCOME; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DOBUTAMINE STRESS ECHOCARDIOGRAPHY; DRUG DOSE INCREASE; DRUG MEGADOSE; ECHOCARDIOGRAPHY; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PROGNOSIS; RISK ASSESSMENT; STRESS ECHOCARDIOGRAPHY; SURVIVAL RATE;

AGED; DIABETES MELLITUS; ECHOCARDIOGRAPHY, STRESS; EXERCISE; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 84859054782     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-1721     Document Type: Article

References (14)

1. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham study. Circulation 1979;59:8-13 (Pubitemid 9082394)
2. Elhendy A, van Domburg RT, Poldermans D, et al. Safety and feasibility of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in diabetic patients unable to perform an exercise stress test. Diabetes Care 1998;21:1797-1802 (Pubitemid 28478273)
3. Chaowalit N, Arruda AL, McCully RB, Bailey KR, Pellikka PA. Dobutamine stress echocardiography in patients with diabetes mellitus: enhanced prognostic prediction using a simple risk score. J Am Coll Cardiol 2006;47:1029-1036
4. Innocenti F, Agresti C, Baroncini C, et al. Prognostic value of dobutamine stress echocardiography in diabetic patients. Int J Cardiovasc Imaging 2010;26:499-507
5. Sozzi FB, Elhendy A, Roelandt JR, et al. Prognostic value of dobutamine stress echocardiography in patients with diabetes. Diabetes Care 2003;26:1074-1078 (Pubitemid 36929251)
6. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-367
7. Bellotti P, Fioretti P, Forster T, et al. Reproducibility of the dobutamine-atropine echocardiography stress test. Echocardiography 1993;10:93-97 (Pubitemid 23113289)
8. Poldermans D, Fioretti PM, Boersma E, et al. Long-term prognostic value of dobutamine-atropine stress echocardiography in 1737 patients with known or suspected coronary artery disease: A single-center experience. Circulation 1999;99:757-762 (Pubitemid 29083015)
9. Arnese M, Fioretti PM, Cornel JH, Postma-Tjoa J, Reijs AE, Roelandt JR. Akinesis becoming dyskinesis during high-dose dobutamine stress echocardiography: a marker of myocardial ischemia or a mechanical phenomenon? Am J Cardiol 1994;73:896-899 (Pubitemid 24158313)
10. Bigi R, Desideri A, Cortigiani L, Bax JJ, Celegon L, Fiorentini C. Stress echocardiography for risk stratification of diabetic patients with known or suspected coronary artery disease. Diabetes Care 2001;24:1596-1601 (Pubitemid 33716455)
11. D'Andrea A, Severino S, Caso P, et al. Prognostic value ofpharmacological stress echocardiography in diabetic patients. Eur J Echocardiogr 2003;4:202-208 (Pubitemid 37069634)
12. Cortigiani L, Bigi R, Sicari R, Landi P, Bovenzi F, Picano E. Prognostic value ofpharmacological stress echocardiography in diabetic and nondiabetic patients with known or suspected coronary artery disease. J Am Coll Cardiol 2006;47:605-610 (Pubitemid 43170852)
13. Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1999;100:1134-1146 (Pubitemid 29416243)
14. Douglas PS, Khandheria B, Stainback RF, et al.; American College of Cardiology Foundation Appropriateness Criteria Task Force; American Society of Echocardiography; American College of Emergency Physicians; American Heart Association; American Society of Nuclear Cardiology; Society for Cardiovascular Angiography and Interventions; Society of Cardiovascular Computed Tomography; Society for Cardiovascular Magnetic Resonance. ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/ SCMR 2008 appropriateness criteria for stress echocardiography: a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, American Society of Echocardiography, American College of Emergency Physicians, American Heart Association, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance: endorsed by the Heart Rhythm Society and the Society of Critical Care Medicine. Circulation 2008;117:1478-1497